International Journal of Internal Medicine

Objective To explore the value of metformin combined with sitagliptin in the treatment of diabetes patients in community hospitals. Methods the subjects were 94 patients with diabetes who were hospitalized in our hospital from June 2020 to July 2021. They were randomly and blindly divided into control group and observation group. During the treatment period, they were treated with metformin and cigliptin respectively. The total effective rate and blood glucose index were counted. Results the total effective rate of the observation group was higher than that of the control group (P<0.05) (χ2=6.114); The indexes of FPG, 2hPG and HbAlc in the observation group were lower than those in the control group (P<0.05) (t1=3.550，t2=3.391，t3=3.668). Conclusion the combination of metformin and sitagliptin can not only effectively enhance the clinical treatment effect, but also effectively regulate the blood glucose level of patients and control it within the normal range. It plays a positive role in improving the quality of life of patients and is suitable for in-depth clinical research and popularization.

Diabetes; Sitagliptin; Metformin; Effective treatment; Blood glucose level